frisium - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

frisium

pharmacy retailing (nz) ltd t/a healthcare logistics - clobazam 10mg - tablet - 10 mg - active: clobazam 10mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch purified talc - adjunctive therapy in partial or generalised epilepsy and monotherapy in certain forms of epilepsy such as lennox-gastaut and catamenial epilepsy.

Australia - English - Department of Health (Therapeutic Goods Administration)

frisium clobazam 10mg tablet blister pack

sanofi-aventis australia pty ltd - clobazam, quantity: 10 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; purified talc; magnesium stearate; colloidal anhydrous silica - adults short term use (up to one month) for the symptomatic management of acute anxiety and sleep disturbances associated with anxiety.,children (4 years of age and over) as adjunctive therapy in patients with partial refractory and lennox-gastaut epilepsy types who are not adequately stabilized with their current anticonvulsant therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

frisium

sanofi-aventis australia pty ltd - clobazam -

Israel - English - Ministry of Health

frisium

sanofi israel ltd - clobazam - tablets - clobazam 10 mg - clobazam - clobazam - frisium is a 1,5-benzodiazepine indicated for the short-term relief (2 – 4 weeks) only of anxiety in adult patients that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short term psychosomatic, organic or psychotic illness.the use of frisium to treat short-term “mild” anxiety is inappropriate and unsuitable.